Fig. 2

Patients achieving ≥ 50% reduction in MMD during a) 12 weeks and at b) 4 weeks. MMD monthly migraine days. ^aP < 0.01 versus placebo. ^bP > 0.05 versus placebo. ^cP < 0.05 versus placebo. ^dP ≤ 0.001 versus placebo